Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Vaccination of children with pneumococcal conjugate vaccine (PCV13) was initiated in Cambodia in 2015. To determine baseline data, we collected samples from children in 2013 and 2014. PCV13 serotypes accounted for 62.7% of colonizing organisms in outpatients and 88.4% of invasive pneumococci overall; multidrug resistance was common. Thus, effectiveness of vaccination should be high.

Original publication

DOI

10.3201/eid2111.150914

Type

Journal article

Journal

Emerging infectious diseases

Publication Date

11/2015

Volume

21

Pages

2080 - 2083

Keywords

Humans, Streptococcus pneumoniae, Pneumonia, Pneumococcal, Pneumococcal Vaccines, Vaccines, Conjugate, Adolescent, Child, Child, Preschool, Infant, Cambodia, Female, Male, Serogroup